newsfilter
← Latest News
GlobeNewswire·

Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity

BOSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to